Health Care & Life Sciences » Medical Equipment & Supplies | NanoRepro AG

NanoRepro AG | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
502.70
-
230.50
530.10
528.10
1,769.70
Total Accounts Receivable
149.40
-
185.60
31.10
331.60
603.50
Inventories
338.10
-
403.30
422.80
735.10
677.80
Other Current Assets
-
-
-
61.40
61.10
82.40
Total Current Assets
990.20
-
819.30
1,045.30
1,655.90
3,133.40
Net Property, Plant & Equipment
38.40
-
20.50
13.30
10.70
6.40
Total Investments and Advances
-
-
-
25.00
25.00
25
Intangible Assets
749.50
-
1,595.60
1,774.90
1,934.80
2,041.50
Other Assets
7.10
-
3.40
97.80
13.90
1.60
Total Assets
1,785.20
-
2,438.80
3,513.40
4,197.30
5,805.90
ST Debt & Current Portion LT Debt
28.40
-
13.50
150.00
129.90
Accounts Payable
68.00
-
73.60
167.20
81.60
Income Tax Payable
5.50
-
6.20
11.00
16.60
Other Current Liabilities
13.50
-
12.90
19.70
63.10
Total Current Liabilities
115.30
-
106.10
347.90
291.10
Long-Term Debt
-
-
-
6.00
6.00
Provision for Risks & Charges
25.40
-
58.50
124.90
76.20
Deferred Taxes
-
-
-
557.00
557.00
Total Liabilities
140.70
-
164.60
478.80
373.30
Common Equity (Total)
1,644.50
-
2,274.20
3,034.60
3,824.00
Total Shareholders' Equity
1,644.50
-
2,274.20
3,034.60
3,824.00
Total Equity
1,644.50
-
2,274.20
3,034.60
3,824.00
Liabilities & Shareholders' Equity
1,785.20
-
2,438.80
3,513.40
4,197.30

About NanoRepro

View Profile
Address
Untergasse 8
Marburg Hessen 35037
Germany
Employees -
Website http://www.nano.ag
Updated 07/08/2019
NanoRepro AG engages in the development, manufacture, and distribution of diagnostic tests and food supplements for home and professional use. It distributes its products under the AllergoCHECK, MilkCHECK, EggCHECK, FertiQUICK, OvuQUICK, GraviQUICK, VagiQUICK, MenoQUICK, GlutenCHECK, Heli-C-CHECK, FerritinCHECK, FOBCHECK, Alkohol Test, and DrugTEST brands. The company was founded by Olaf Stiller in 2006 and is headquartered in Marburg, Germany.

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.